The need to accessorize: molecular roles of HTLV-1 p30 and HTLV-2 p28 accessory proteins in the viral life cycle
暂无分享,去创建一个
[1] L. Ratner,et al. Human T-Cell Lymphotropic Virus Type 1 Open Reading Frame II-Encoded p30II Is Required for In Vivo Replication: Evidence of In Vivo Reversion , 2004, Journal of Virology.
[2] K. Jeang,et al. A Human T-cell Leukemia Virus Tax Variant Incapable of Activating NF-κB Retains Its Immortalizing Potential for Primary T-lymphocytes* , 1998, The Journal of Biological Chemistry.
[3] K. Jeang,et al. Molecular mechanisms of cellular transformation by HTLV-1 Tax , 2005, Oncogene.
[4] M. Osame,et al. Antibody reactivities to tumor‐suppressor protein p53 and HTLV‐I Tof, Rex and Tax in HTLV‐I‐infected people with differing clinical status , 1997, International journal of cancer.
[5] T. Misteli,et al. HTLV-1-encoded p30II is a post-transcriptional negative regulator of viral replication , 2004, Nature Medicine.
[6] W. Ding,et al. Human T-Lymphotropic Virus Type 1 p30IIFunctions as a Transcription Factor and Differentially Modulates CREB-Responsive Promoters , 2000, Journal of Virology.
[7] K. Raska. [GLOBAL EPIDEMIOLOGY]. , 1964, Ceskoslovenska epidemiologie, mikrobiologie, imunologie.
[8] J. Desmyter,et al. HTLV-II among pygmies , 1992, Nature.
[9] W. Blattner,et al. Isolation of human T-cell lymphotropic virus type 2 from Guaymi Indians in Panama. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[10] R. Anupam,et al. Human T-lymphotropic Virus Type 1 p30 Interacts with REGγ and Modulates ATM (Ataxia Telangiectasia Mutated) to Promote Cell Survival* , 2011, The Journal of Biological Chemistry.
[11] John D. Minna,et al. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma , 1980, Proceedings of the National Academy of Sciences.
[12] M. Cole,et al. A Human T-Cell Lymphotropic Virus Type 1 Enhancer of Myc Transforming Potential Stabilizes Myc-TIP60 Transcriptional Interactions , 2005, Molecular and Cellular Biology.
[13] Joshua Arnold,et al. Enhancement of infectivity and persistence in vivo by HBZ, a natural antisense coded protein of HTLV-1. , 2006, Blood.
[14] P. Green,et al. Human T-Cell Leukemia Virus Open Reading Frame II Encodes a Posttranscriptional Repressor That Is Recruited at the Level of Transcription , 2006, Journal of Virology.
[15] P. Mckinnon. DNA repair deficiency and neurological disease , 2009, Nature Reviews Neuroscience.
[16] Anke Busch,et al. Evolution of SR protein and hnRNP splicing regulatory factors , 2012, Wiley interdisciplinary reviews. RNA.
[17] L. Ratner,et al. Immortalization of CD4+ and CD8+ T Lymphocytes by Human T-Cell Leukemia Virus Type 1 Tax Mutants Expressed in a Functional Molecular Clone , 1999, Journal of Virology.
[18] K. Vermeulen,et al. The cell cycle: a review of regulation, deregulation and therapeutic targets in cancer , 2003, Cell proliferation.
[19] L. Ratner,et al. Human T-lymphotropic virus type-1 p30 alters cell cycle G2 regulation of T lymphocytes to enhance cell survival , 2007, Retrovirology.
[20] T. Ross,et al. Human T-Cell Leukemia Virus Type 2 Tax Mutants That Selectively Abrogate NFκB or CREB/ATF Activation Fail To Transform Primary Human T Cells , 2000, Journal of Virology.
[21] Adeeba Kamarulzaman,et al. AIDS Res Hum Retroviruses , 2006 .
[22] F. Proietti,et al. Epidemiology, Treatment, and Prevention of Human T-Cell Leukemia Virus Type 1-Associated Diseases , 2010, Clinical Microbiology Reviews.
[23] W. Heneine,et al. HTLV-II endemicity among Guaymi Indians in Panama. , 1991, The New England journal of medicine.
[24] M. Lairmore,et al. Human T-cell leukemia virus type 2 post-transcriptional control protein p28 is required for viral infectivity and persistence in vivo , 2008, Retrovirology.
[25] S. Landry,et al. Human T-cell leukemia virus type 2 produces a spliced antisense transcript encoding a protein that lacks a classic bZIP domain but still inhibits Tax2-mediated transcription. , 2009, Blood.
[26] G. de Thé,et al. Evidence of HTLV-II infection in Guinea, West Africa. , 1993, Journal of acquired immune deficiency syndromes.
[27] I. Koralnik,et al. The p12I, p13II, and p30II proteins encoded by human T-cell leukemia/lymphotropic virus type I open reading frames I and II are localized in three different cellular compartments , 1993, Journal of virology.
[28] M. Reitz,et al. Expression of alternatively spliced human T-lymphotropic virus type I pX mRNA in infected cell lines and in primary uncultured cells from patients with adult T-cell leukemia/lymphoma and healthy carriers. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[29] W. Greene,et al. Identification of HTLV-I tax trans-activator mutants exhibiting novel transcriptional phenotypes. , 1990, Genes & development.
[30] L. Chieco‐Bianchi,et al. Expression and characterization of proteins produced by mRNAs spliced into the X region of the human T-cell leukemia/lymphotropic virus type II. , 1995, Virology.
[31] P. Green,et al. The human T-cell leukemia virus Rex protein. , 2005, Frontiers in bioscience : a journal and virtual library.
[32] F. Ruscetti,et al. X-I and X-II open reading frames of HTLV-I are not required for virus replication or for immortalization of primary T-cells in vitro. , 1997, Virology.
[33] C. Nicot,et al. HTLV-I p30 inhibits multiple S phase entry checkpoints, decreases cyclin E-CDK2 interactions and delays cell cycle progression , 2010, Molecular Cancer.
[34] E. Murphy,et al. Global epidemiology of HTLV-I infection and associated diseases , 2005, Oncogene.
[35] M. Yoshida,et al. p27x-III and p21x-III, proteins encoded by the pX sequence of human T-cell leukemia virus type I. , 1985, Proceedings of the National Academy of Sciences of the United States of America.
[36] Yu-Jie Hu,et al. Versatility of PRMT5-induced methylation in growth control and development. , 2011, Trends in biochemical sciences.
[37] I. Chen,et al. A deletion in the proximal untranslated pX region of human T-cell leukemia virus type II decreases viral replication but not infectivity in vivo. , 1996, Blood.
[38] Mitsuaki Yoshida. Discovery of HTLV-1, the first human retrovirus, its unique regulatory mechanisms, and insights into pathogenesis , 2005, Oncogene.
[39] Kuan-Teh Jeang,et al. Human T-cell leukaemia virus type 1 (HTLV-1) infectivity and cellular transformation , 2007, Nature Reviews Cancer.
[40] K. Takatsuki,et al. Discovery of adult T-cell leukemia , 2005, Retrovirology.
[41] L. Ratner,et al. Histone acetyltransferase (HAT) activity of p300 modulates human T lymphotropic virus type 1 p30II-mediated repression of LTR transcriptional activity. , 2006, Virology.
[42] R. Anupam,et al. Comparative host protein interactions with HTLV-1 p30 and HTLV-2 p28: insights into difference in pathobiology of human retroviruses , 2012, Retrovirology.
[43] A. Vandamme,et al. HTLV-II seroprevalence in pygmies across Africa since 1970. , 1993, AIDS research and human retroviruses.
[44] M. Biard-Piechaczyk,et al. The Complementary Strand of the Human T-Cell Leukemia Virus Type 1 RNA Genome Encodes a bZIP Transcription Factor That Down-Regulates Viral Transcription , 2002, Journal of Virology.
[45] Joshua Arnold,et al. Human T-cell leukemia virus type-1 antisense-encoded gene, Hbz, promotes T-lymphocyte proliferation. , 2008, Blood.
[46] S. Buch,et al. The HTLV-I p30 Interferes with TLR4 Signaling and Modulates the Release of Pro- and Anti-inflammatory Cytokines from Human Macrophages* , 2006, Journal of Biological Chemistry.
[47] N. Clark,et al. Direct Evidence , 1934 .
[48] Massimo Caputi,et al. SR proteins and hnRNP H regulate the splicing of the HIV‐1 tev‐specific exon 6D , 2002, The EMBO journal.
[49] P. Green,et al. Detection and quantitation of HTLV-1 and HTLV-2 mRNA species by real-time RT-PCR. , 2007, Journal of virological methods.
[50] L. Gazzolo,et al. Regulation of the human T-cell leukemia virus gene expression depends on the localization of regulatory proteins Tax, Rex and p30II in specific nuclear subdomains. , 2007, Gene.
[51] G. Pavlakis,et al. The pX protein of HTLV-I is a transcriptional activator of its long terminal repeats. , 1985, Science.
[52] A. Rosato,et al. The human T-cell lymphotropic virus type 1 Tof protein contains a bipartite nuclear localization signal that is able to functionally replace the amino-terminal domain of Rex , 1997, Journal of virology.
[53] P. Mckinnon. DNA repair deficiency and neurological disease , 2009, Nature Reviews Neuroscience.
[54] D. McFarlin,et al. HTLV‐I‐specific cytotoxic T lymphocytes in the cerebrospinal fluid of patients with HTLV‐I‐associated neurological disease , 1992, Annals of neurology.
[55] A. Ureta-Vidal,et al. Evidence for the Chronic in Vivo Production of Human T Cell Leukemia Virus Type I Rof and Tof Proteins from Cytotoxic T Lymphocytes Directed against Viral Peptides , 2000, The Journal of experimental medicine.
[56] C. Nicot,et al. Human T-cell Lymphotrophic Virus Type I Rex and p30 Interactions Govern the Switch between Virus Latency and Replication* , 2007, Journal of Biological Chemistry.
[57] B. Hjelle,et al. High frequency of human T-cell leukemia-lymphoma virus type II infection in New Mexico blood donors: determination by sequence-specific oligonucleotide hybridization. , 1990, Blood.
[58] M. Dundr,et al. Repression of Human T-Cell Leukemia Virus Type 1 and Type 2 Replication by a Viral mRNA-Encoded Posttranscriptional Regulator , 2004, Journal of Virology.
[59] I. Chen,et al. Regulation of human T cell leukemia virus , 1990 .
[60] J. Bartek,et al. The DNA-damage response in human biology and disease , 2009, Nature.
[61] M. Dundr,et al. PA28γ is a novel corepressor of HTLV-1 replication and controls viral latency. , 2013, Blood.
[62] Christophe Nicot,et al. Genome wide analysis of human genes transcriptionally and post-transcriptionally regulated by the HTLV-I protein p30 , 2009, BMC Genomics.
[63] G. Draetta,et al. Cdc25 protein phosphatases in cell proliferation. , 1997, Biochimica et biophysica acta.
[64] F. Ruscetti,et al. Requirement of the human T-cell leukemia virus p12 and p30 products for infectivity of human dendritic cells and macaques but not rabbits. , 2010, Blood.
[65] Z. Berneman,et al. Protein isoforms encoded by the pX region of human T-cell leukemia/lymphotropic virus type I. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[66] G. Pavlakis,et al. Complex splicing in the human T-cell leukemia virus (HTLV) family of retroviruses: novel mRNAs and proteins produced by HTLV type I , 1992, Journal of virology.
[67] L. Ratner,et al. Functional Role of pX Open Reading Frame II of Human T-Lymphotropic Virus Type 1 in Maintenance of Viral Loads In Vivo , 2000, Journal of Virology.
[68] M. Yoshida,et al. Isolation and characterization of retrovirus from cell lines of human adult T-cell leukemia and its implication in the disease. , 1982, Proceedings of the National Academy of Sciences of the United States of America.
[69] Prabhakar R. Gudla,et al. Human T-cell leukemia virus type 1 p8 protein increases cellular conduits and virus transmission , 2010, Proceedings of the National Academy of Sciences.
[70] J. Drummond,et al. HTLV-II infection in Florida Indians. , 1993, AIDS research and human retroviruses.
[71] C. Stevens,et al. Aquaporin 4 and glymphatic flow have central roles in brain fluid homeostasis , 2021, Nature Reviews Neuroscience.
[72] M. Yoshida,et al. Direct evidence that p40x of human T‐cell leukemia virus type I is a trans‐acting transcriptional activator. , 1986, The EMBO journal.
[73] C. Casoli,et al. Temporal regulation of HTLV-2 expression in infected cell lines and patients: evidence for distinct expression kinetics with nuclear accumulation of APH-2 mRNA , 2012, Retrovirology.
[74] W. Hall,et al. Human T‐lymphotropic virus type II and neurological disease , 2004, Annals of neurology.
[75] A. Poustka,et al. Systematic subcellular localization of novel proteins identified by large‐scale cDNA sequencing , 2000, EMBO reports.
[76] M. Vidal,et al. Host-pathogen interactome mapping for HTLV-1 and -2 retroviruses , 2012, Retrovirology.
[77] M. Dundr,et al. Human T-cell Leukemia Virus Type I p30 Nuclear/Nucleolar Retention Is Mediated through Interactions with RNA and a Constituent of the 60 S Ribosomal Subunit* , 2006, Journal of Biological Chemistry.
[78] K. Yamaguchi,et al. Adult T-Cell Leukemia: A Review of Epidemiological Evidence , 2012, Front. Microbio..
[79] A. Corradin,et al. Kinetics and intracellular compartmentalization of HTLV-1 gene expression: nuclear retention of HBZ mRNAs. , 2011, Blood.
[80] M. Lairmore,et al. Human T lymphotropic virus type-1 p30II alters cellular gene expression to selectively enhance signaling pathways that activate T lymphocytes , 2004, Retrovirology.
[81] Ross Smith,et al. Functional diversity of the hnRNPs: past, present and perspectives. , 2010, The Biochemical journal.
[82] F. Kashanchi,et al. Human T-Lymphotropic Virus Type 1 p30IIRegulates Gene Transcription by Binding CREB Binding Protein/p300 , 2001, Journal of Virology.
[83] R. Anupam,et al. Mechanisms of human T-lymphotropic virus type 1 transmission and disease. , 2012, Current opinion in virology.
[84] C. Nicot,et al. Human T-lymphotropic type 1 virus p30 inhibits homologous recombination and favors unfaithful DNA repair. , 2011, Blood.
[85] Sharmistha Pal,et al. Protein Arginine Methyltransferase 5 Suppresses the Transcription of the RB Family of Tumor Suppressors in Leukemia and Lymphoma Cells , 2008, Molecular and Cellular Biology.
[86] L. Ratner,et al. Human T-Cell Leukemia Virus Type 1 pX-I and pX-II Open Reading Frames Are Dispensable for the Immortalization of Primary Lymphocytes , 1998, Journal of Virology.